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Abstract 
A series of complexes of cyclic (alkyl)(amino)carbene (CAAC) complexes of copper, silver 
and gold have been investigated for their antiproliferative properties. A second series of 
acyclic carbene (ACC) complexes of gold(I) were prepared by nucleophilic attack on 
isocyanide complexes by amines and amino esters, to give (ACC)AuCl, [(ACC)Au(PTA)]+ 
(PTA = triazaphosphaadamantane), as well as mixed-carbene compounds 
[(CAAC)Au(ACC)]+. Representative complexes were characterised by X-ray diffraction 
which confirmed the mononuclear linear structures without close intermolecular contacts or 
aurophilic interactions. The redox properties of these complexes have been determined. The 
compounds were tested against a panel of human cancer cell lines including leukemia (HL 
60), breast adenocarcinoma cells (MCF-7) and human lung adenocarcinoma epithelial cell 
lines (A549), which show varying degrees of cisplatin resistance. The pro-ligand iminium 
salts and the PTA complexes were non-toxic. By contrast, the CAAC complexes show high 
cytotoxicity, with IC50 values in the sub-micromolar to ~100 nanomolar range, even against 
cisplatin-insensitive MCF-7 and A549 cells. Cationic bis-carbene complexes 
[(Me2CAAC)2M]
+ (6 – 8, M = Cu, Ag and Au) proved particularly effective. The mechanism 
of cell growth control by these complexes remains to be established, although possible modes 
of action such as inhibition of thioredoxin reductase (TrxR), which is a common pathway for 
gold NHC compounds, or the formation of reactive oxygen species (ROS) through redox 
processes, could be ruled out as primary pathways.  
 
Introduction 
Carbene complexes of copper(I), silver(I) and gold(I) have been shown to display promising 
activities as antiproliferative agents towards a large number of cancer cell lines. Gold 
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complexes have been extensively studied, and their structures and cytotoxicity profiles have 
been the subject of a number of reviews.1-6 Copper is an essential trace element and 
participates in a wide variety of catalytic functions in the body. Its homeostasis is guaranteed 
by different active transporters and chaperones. Copper complexes are being discussed in 
connection with developing treatments against a range of diseases, including 
neurodegenerative diseases, Alzheimer’s and Parkinson’s disease, as well as cancers.7 Most 
of the compounds studied for anti-cancer activity are based on copper(II), and its cytotoxic 
activity is thought to be possibly related to its redox behaviour and generation of reactive 
oxygen species (ROS), to mitochondrial toxicity, to binding to intracellular thiols and 
interference in respiratory processes, as well as DNA cleavage and activation of apoptotic 
pathways in cancer cells.8-11  
Carbene complexes of silver-too, have become attractive for their cytotoxic activity, 
which in some cases exceeds that of gold analogues.12-16 The ligands used in these 
compounds are N-heterocyclic carbenes (NHCs) based on the imidazole framework and may 
be mono- or bi-dentate. NHC complexes generally fall into two categories: (i) mono-carbene 
adducts of metals salts that also carry a labile ligand X, such as in (NHC)MX, usually X = 
halide, where the X ligand can be expected to be readily substituted under physiological 
conditions and is susceptible to substitution by intracellular thiols; (ii) ionic bis-carbene 
complexes [M(NHC)2]
+X-, which may be redox active but can only bind to thiols after 
carbene dissociation. In any case, silver NHC complexes are known for their lability and have 
long been used as NHC transfer reagents for the synthesis of NHC complexes of other 
metals.17,18 This implies that the structural integrity of (NHC)Ag compounds under 
physiological conditions cannot be taken for granted, so that establishing quantitative 
structure-activity relationships may not be straightforward.  
In the present study we have chosen cyclic (alkyl)(amino)carbene (CAAC) ligands19-21 
coordinated to coinage metals to investigate the potential of these complexes as anti-
proliferative agents. CAAC ligands have the advantage over NHCs that they bind 
significantly more strongly and are not prone to dissociation.22 For example, CAAC ligands 
have been found capable of forming stable complexes even with zero-valent gold and 
copper.23 For these reasons CAAC silver complexes are rather poor carbene transfer agents; 
for example they failed to give the expected carbene transfer to rhodium and ruthenium 
targets.24 These characteristics are however beneficial for biological applications, as further 
supported by recent results on polycyclic CAAC complexes reported by Waldmann and co-
workers.25  
Page 2 of 31Dalton Transactions
D
al
to
n
Tr
an
sa
ct
io
ns
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
23
 O
ct
ob
er
 2
01
7.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f E
as
t A
ng
lia
 L
ib
ra
ry
 o
n 
31
/1
0/
20
17
 1
0:
20
:4
2.
 
View Article Online
DOI: 10.1039/C7DT03189K
3 
 
We also report the extension of carbene anti-cancer complexes to acyclic carbenes, in 
combination with CAAC and other ligands. Acyclic carbenes (ACC) offer the advantage of 
facile modification and functionalization via a common precursor and provide a potentially 
very versatile method for improving solubility, cell uptake and selectivity of cytotoxicity. 
Although acyclic carbene adducts of gold were among the first examples of carbene 
complexes to be reported,26 their biological activity has hardly been explored.27  
 
Results and Discussion 
Synthesis and Structure. The compounds (CAAC)MCl 1 – 5 (M = Cu, Ag, Au, Chart I) and 
of the bis-carbene compounds [(Me2CAAC)2M]X (6, M = Cu, X = I; 7, M = Ag, X = OTf; 8, 
M = Au, X = Cl) were prepared following previously reported procedures.19c,21,22a,24 Due to 
steric hindrance bis-CAAC complexes can be obtained only for methyl- and ethyl substituted 
CAAC ligands but not for adamantyl-substituted CAAC. The iminium salt ligand precursors 
Me
LH, EtLH and AdLH were also included in the toxicity testing programme for comparison. 
All the metal complexes are mononuclear in solution and in the solid state.  
 
 
Chart I: Structure of the CAAC-M(I) complexes 1-8 and the corresponding pro-ligands. 
 
Complexes with a combination of CAAC and acyclic carbene ligands were obtained by 
nucleophilic addition of amines and amino esters to gold(I) isocyanide complexes,26 as 
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outlined in Scheme 1. Both neutral complexes (ACC)AuCl and ionic complexes 
[(L)Au(ACC)]+X- were prepared to evaluate the influence of charge and solubility (ACC = 
acyclic carbene; L = AdCAAC or triazaphosphaadamantane, PTA). The reaction of gold 
isocyanide complexes (RNC)AuCl (R = xylyl, tBu) with pyrrolidine in dichloromethane at 
room temperature in the dark gave compounds 9a and 9b as white powders. Similarly, the 
reaction of sarcosine hydrochloride in acetonitrile in the presence of potassium carbonate 
afforded the amino acid derivatives 10a and 10b as orange to purple powders in good yields. 
The chloride ligands in 9 and 10 can be readily be substituted by PTA, chosen because of its 
water solubility, to give the ionic complexes 11a,b and 12a,b, respectively (Scheme 1). The 
structures of 11a and 11b were confirmed by X-ray crystallography (vide infra). In solution 
12a appears as a mixture of the two possible orientations of the sarcosine substituent of the 
ACC ligand in a ratio of approximately 0.75:0.25, while complex 12b exists in solution as a 
mixture of all four possible stereoisomers of the ACC ligand; these lead to distinct 1H NMR 
resonances for the N-H hydrogen with an integration ratio of approximately 0.1:0.2:0.2:0.5.  
The reaction of (AdCAAC)AuCl with xylyl isocyanide and silver hexafluoroantimonate 
in dichloromethane under anhydrous conditions afforded the isocyanide complex 13a, which 
reacted with pyrrollidine in acetonitrile gave the mixed-carbene complex 14a as a white 
powder in 76% yield.  
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Scheme 1. Synthesis of neutral and ionic gold(I) complexes of acyclic carbenes 
 
X-ray diffraction studies. The molecular structures of representative neutral and ionic 
ACC complexes with and without amino acid substituents were determined by X-ray 
diffraction (Figure 1). The structures of the CAAC complexes 13a and 14a are shown in 
Figure 2. All compounds show an almost linear coordination geometry, with the largest 
deviation observed for the bulky mixed-carbene complex 14a (C1–Au–C28 173.4(1)°). The 
Au–C (ca. 2.00 Å) and Au–Cl (ca. 2.29 Å) bond lengths deviate within the error of the 
experiment for the complexes 9a, 10a and 10b while being almost equidistant with other 
(ACC)AuCl reported in the literature.28 The Au–C bond length for complex 11a is elongated 
by 0.06 Å  compared to complexes 9–10 due to moderate structural trans-influence of the 
phosphine (PTA) ligand vs. chloride anion, in accordance with the general trend.29 The 
mixed-carbene complex 14a shows that the Au–CCAAC bond length is slightly shorter than 
Au–CACC. The open chain carbene ligands possess an essentially planar geometry with N–C–
N angles greater than 116°, similar to the values previously observed for acyclic carbene 
ligands.28 None of complexes show aurophilic metal-metal interactions. The molecules are 
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arranged into a three-dimensional network of weak interactions, based on N1–H1A···X (X = 
N, O, or F) hydrogen bonds between neighbouring molecules.  
 
 
 
Figure 1. Molecular structures of 9a (top left), 10a (top right), 10b (bottom left) and the 
cation in 11a (bottom right). Ellipsoids are shown at the 50% level. Except for N-H, 
hydrogen atoms are omitted for clarity. Selected bond distances [Å] and angles [°]: 9a: Au1–
C1 1.999(3), Au1–Cl1 2.2891(8), C1–N1 1.342(4), C1–N2 1.323(4); C1–Au1–Cl1 178.68(9), 
N1–C1–N2 117.6(3). 10a: Au1–C1 2.006(5), Au1–Cl1 2.2977(12), C1–N1 1.325(6), C1–N2 
1.342(6); C1–Au1–Cl1 176.37(15), N1–C1–N2 117.3(4). 10b: Au1–C1 2.011(2), Au1–Cl1 
2.2929(5), C1–N1 1.324(2), C1–N2 1.340(2); C1–Au1–Cl1 176.78(5), N1–C1–N2 
117.27(17). 11a: Au1–C1 2.065(3), Au1–P1 2.2725(7), C1–N1 1.339(3), C1–N2 1.308(4); 
C1–Au1–P1 178.38(8), N1–C1–N2 118.6(2).  
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Figure 2. Molecular structures of the complex cations in 13a (left), and 14a (right). 
Ellipsoids are shown at the 50% level. Except for N-H, hydrogen atoms are omitted for 
clarity. Selected bond distances [Å] and angles [°]: 13a: Au1–C1 2.034(3), Au1–C28 
1.971(3), C1–C2 1.520(3), C1–N1 1.294(3), N2–C28 1.153(4); C1–Au–C28 174.51(11), Au–
C28–N2 173.5(3). 14a: Au1–C1 2.037(3), Au1–C28 2.043(3), C1–C2 1.530(4), C1–N1 
1.302(4), N2–C28 1.326(4), C28–N3 1.337(4); C1–Au–C28 173.4(1), N2–C28–N3 116.4(3). 
 
Electrochemistry. Cyclic voltammetry (CV) was used to analyse the redox behaviour of 
the CAAC copper, silver and gold complexes in MeCN and THF solutions using [nBu4N]PF6 
or [nBu4N][B(C6F5)4] as the supporting electrolytes (Table 1). The mono(carbene) silver 
chloride 4 in MeCN undergoes an irreversible reduction process with an anodic shift 
compared to the analogous copper (1, 240 mV) and gold compounds (5, 160 mV). A re-
oxidation peak from the reduction process could not be detected at all scan rates from 0.05 to 
2 Vs–1 in MeCN, likely due to reaction with the electrolyte or solvent. To solve this problem 
we have performed cyclic voltammetry in THF with the less nucleophilic supporting 
electrolyte [nBu4N][B(C6F5)4]. In this solvent the reduction process shows quasi-reversible 
character but at a significantly lower potential, with E1/2  at -1.62 V (Figure 3). This indicates 
the feasibility of chemical reduction of the silver complex 4. Its oxidation behaviour is very 
similar to the copper and gold analogues and at all scan rates shows one irreversible process 
without a back-peak, regardless of the solvent or supporting electrolyte.  
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Figure 3. Full range cyclic voltammogram of (AdCAAC)AgCl (4), recorded using a glassy 
carbon electrode in THF solution (0.7 mM) with [nBu4N][B(C6F5)4] as supporting electrolyte 
(0.13 M).  
 
The ionic homoleptic bis(carbene) complexes [(Me2CAAC)2M]X (M = Ag, X = OTf; M 
= Au, X = BF4) show quasi-reversible one-electron reduction processes (Figure 4), with a 
significant anodic shift of the reduction potential E1/2 by 200 mV compared to mono(carbene) 
metal chloride complexes (see Table 1). The quasi-reversibility of the reduction peak is 
witnessed by the negligible shift of 10 mV in the peak position Ep on increasing the scan rate 
and the peak-to-peak separation ∆Ep of 66–94 mV (at 100 mV/s), which is close to the ideal 
value of 59 mV for a one-electron reversible couple. Both silver (7) and gold (8) complexes 
show ipa/ipc values approaching unity, which is the ideal value for a reversible couple. For 
instance, the ipa/ipc ratio increases from 0.33 (at 50 mVs
–1) to 0.54 (at 2 Vs–1) for silver 
[(Me2CAAC)2Ag]OTf and from 0.49 (at 50 mVs
–1) to 0.80 (at 2 Vs–1) for gold complex 
[(Me2CAAC)2Au]BF4 (Figure 4). The reversibility of the reduction process for silver (7) and 
gold (8) complexes is markedly different from the copper analogue [(Me2CAAC)2Cu]I (6), 
which shows quasi-reversible reduction only at high scan rates (0.5 to 2 Vs–1). By contrast, at 
all scan rates the heteroleptic bis-carbene gold complex 14a showed irreversible reduction 
(Figure 4), which was shifted cathodically by 220 mV compared to the homoleptic gold 
complex 8.  
Unlike the bis-carbene copper complex 6, the irreversible oxidation of silver (7) and 
gold complexes 8 and 14a is observed at high anodic potential as expected (1.33 V for silver 
and over 1.63 V for gold complexes) (Table 1). The oxidation potential for 8 was completely 
masked by solvent discharge (THF or MeCN), while silver (7) and the heteroleptic gold 
complex 14a showed only partial overlap (Figure 4). We have previously reported that 
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chemical oxidation of mono-carbene and bis-carbene gold complexes with PhICl2 produced 
photochemically unstable Au(III) complexes or decomposition products.21 
 
Table 1. Formal electrode potentials (peak position Ep for irreversible and E1/2 for quasi-
reversible processes (*), V, vs. FeCp2), onset potentials (E, V, vs. FeCp2), peak-to-peak 
separation in parentheses for quasi-reversible processes (∆Ep in mV), EHOMO/ELUMO (eV) and 
band gap values (∆E, eV) for the redox changes exhibited by copper, silver, and gold 
complexes.   
Complex 
Reduction 
ELUMO 
eV 
Oxidation 
EHOMO 
eV 
∆E 
eV EM(I)/M(0) 
Eonset 
red 
E1st Eonset ox E2nd 
1 (AdL)CuCl a −2.65 −2.60 −2.79 +0.67 +0.59 − −5.98 3.19 
2 (Et2L)CuCl a –2.82 –2.71 −2.68 +0.57 +0.35 +0.80 –5.74 3.21 
3 (Me2L)CuCl a –2.70 –2.57 −2.82 +0.53 +0.24 +0.78 –5.63 2.81 
4 (AdL)AgCl a –2.41 –2.33 −3.06 +1.26 +1.06 − −6.45 3.39 
4 (AdL)AgCl b –1.62*(125) –1.55 −3.84 +0.93 +0.80 – −6.19 2.35 
5 (AdL)AuCl a −2.57 −2.52 −2.87 +1.46 +1.34 − −6.73 3.86 
6 [(Me2L)2Cu]I
 a −2.47*(65) −2.39 −3.00 +0.02 −0.11 +0.27 –5.28 2.28 
7 [(Me2L)2Ag]OTf
a −2.44* (66) −2.37 −3.02 −c −c − − − 
7 [(Me2L)2Ag]OTf
 b −2.50* (94) −2.43 −2.96 +1.33c +1.16 − −6.55 3.59 
8 [(Me2L)2Au]BF4
 a
 –2.22* (85) –2.16 –3.23 −c −c − − − 
14a 
[(AdL)Au(ACC)]+ 
SbF6
- d  
–2.44 –2.31 –3.08 +1.63 +1.45 – –6.84 3.76 
a Recorded using a glassy carbon electrode, concentration 1.4 mM in acetonitrile, supporting 
electrolyte [nBu4N][PF6] (0.13 M), measured at 0.1 V s
−1. b Recorded using a glassy carbon electrode, 
concentration 0.7 mM in THF, supporting electrolyte [nBu4N][B(C6F5)4] (0.13 M), measured at 0.1 V 
s−1. c Overlaps with solvent discharge. d Recorded using a glassy carbon electrode, concentration 2.0 
mM in MeCN, supporting electrolyte [nBu4N][PF6] (0.13 M), measured at 0.1 V s
−1.  
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Figure 4. Top Left: full range cyclic voltammogram of homoleptic complex 
[(Me2CAAC)2Au]BF4 (8). Top right: Varied scan rate behaviour recorded using a glassy 
carbon electrode in MeCN solution (1.4 mM) with [nBu4N][PF6] as supporting electrolyte 
(0.13 M). Bottom left: full range cyclic voltammogram of the open-chain carbene complex 
14a. Bottom right: Varied scan rate behaviour recorded using a glassy carbon electrode in 
MeCN solution (2.0 mM) with [nBu4N][PF6] as supporting electrolyte (0.13 M). 
 
Antiproliferative properties on cancer cells in vitro. Although the complexes appeared 
to be poorly soluble in aqueous media, all compounds were soluble enough in DMSO not to 
precipitate when diluted with aqueous buffer solution up to 100 µM with 1% DMSO. Stock 
solutions of cisplatin were prepared in pure water. For an initial screening, the CAAC 
complexes 1 - 8 were selected for the determination of the IC50 on a panel of human cancer 
cell lines including leukemia (HL 60), breast adenocarcinoma cells (MCF-7) and human lung 
adenocarcinoma epithelial cells (A549) (Table 2).  
Table 2. Effect of compounds 1-8, 14a, the pro-ligand iminium salts AdLH, EtLH and MeLH 
and cisplatin on viability of cancer cell lines (IC50, µM) after 72 h incubation.  
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Complex HL 60 MCF-7 A549 
1 0.14 ± 0.06 0.49 ± 0.02 17.4 ± 0.8 
2 0.12 ± 0.01 0.32 ± 0.02 0.53 ±0.06 
3 0.32 ± 0.04 0.57 ± 0.07 2.0 ± 0.5 
4 0.18 ± 0.06 0.32 ± 0.10 5.7 ± 0.7 
5 2.2 ± 0.2 4.1 ± 0.8 43.8 ± 0.4 
6 0.13 ± 0.03 1.4 ± 0.6 0.31 ± 0.08 
7 0.10 ± 0.01 1.2 ± 0.3 0.39 ± 0.06 
8 0.09 ± 0.01 1.6 ± 0.6 0.5 ± 0.1 
14a 0.10 ± 0.01 2.3 ± 0.9 6.1 ± 0.3 
Cisplatin 3.7 ± 0.3 21.2 ± 3.9 33.7 ± 3.7 
Ad
LH 8.0 ± 1.3 9.03 ± 0.09 > 50 
Me
LH > 50 > 50 > 50 
Et
LH > 50 19.5 ± 4.9 > 50 
 
All three ligand precursors RLH are non-toxic. The metal complexes, irrespective of 
whether they are neutral halides or of the ionic bis-carbene type, are particularly active on HL 
60, and MCF-7 cell lines, with IC50 values from the low-micromolar to the ~100 nanomolar 
range. These complexes are substantially more active than cisplatin. The copper complexes 1 
– 3 show high activity against HL-60 and MCF-7, with IC50 values in the low submicromolar 
range. Their activity against A549, a cell line which typically shows high cisplatin resistance, 
is about an order of magnitude lower. The exception here is the surprisingly low activity of 
(AdCAAC)CuCl 1 against A549, which contrasts with the low IC50 value of only 0.53 ±0.06 
µM for the ethyl analogue, (EtCAAC)CuCl 2. The silver complex (AdCAAC)AgCl 4 is 
slightly more toxic than its copper analogue 1 on the MCF-7 cells. Overall 4 shows a similar 
trend: sub-micromolar activity against HL-60 and MCF-7 and low micromolar values against 
the more resistant A549 lines. These copper and silver CAAC complexes are an order of 
magnitude more potent than the gold complex 5, which is less effective than copper and 
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silver against HL-60 and MCF-7 and, surprisingly, non-toxic against A549. In the series of 
adamantyl-substituted CAAC complexes, against HL-60, MCF-7 and A549 silver shows the 
highest and gold the lowest cytotoxicity: IC50(5) > IC50(1) ≥ IC50(4). On the other hand, such 
a metal dependence has been not observed in the cationic series, for which very similar, and 
remarkably low, IC50 values were determined for all metals against each of the tested cancer 
cell lines. Indeed, all [(CAAC)2M]
+ complexes 6 - 8 demonstrated very strong antiproli-
ferative effects, with IC50 values down up to sub-micromolar levels, including against A549 
cells which are particularly difficult to treat with cisplatin.  
Varying the substituents on the CAAC ligand in the copper series leads to only small 
differences in activity against HL 60 and MCF-7 cell lines, while against A549 cells a 
dramatic substituent dependence of the cytotoxic properties was observed (IC50 = 17.4 ± 0.8; 
0.53 ± 0.06 and 2.0 ± 0.5 µM for 1, 2 and 3 respectively), indicating that Et2CAAC complexes 
are the most toxic of this series.  
The acyclic carbene complexes 9 – 12 and 14a were screened against lung (A549) and 
breast (MCF-7) cancer cells at concentrations of 10 and 100 µM. The cell viability was 
measured after 72 hours of incubation using the standard MTS assay (see experimental part). 
The results are reported in Figure 5.  
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Figure 5: Inhibition of A) A549 cells and B) MCF-7 cells proliferation by ACC complexes 9 
– 12 and 14a; data represent the average ± standard error of three experiments. 
 
None of the PTA complexes 11 - 12 showed any cell growth inhibition against the lung 
cancer cells at both tested concentrations (A549, Fig. 5A). In the chloro series 9 - 10, 
compounds 9a, 9b and 10b demonstrated a strong antiproliferative effect at 100 µM (cell 
viability of 4.2 ± 1.9, 3.8 ± 2.0 and 15.8 7.3 % respectively), while compound 10a bearing an 
ACC ligand with 2,6-Me2C6H3 and sarcosine substituents appeared completely inactive at 
both tested concentrations. None of the chloro and PTA complexes 9 – 12 showed any 
proliferative activity against MCF-7 at the lower concentration of 10 µM (Fig. 5B). 
Moreover, while complexes 9a, 9b, 10b, 11a, 11b and 12b completely inhibited cell growth 
at the higher concentration of 100 µM, the two complexes presenting the ACC ligand with 
the xylyl/sarcosine combination, 10a and 12a, appeared to have a reduced activity even at 
that high concentration (cell viability of 20.2 ± 7.7 and 71 ± 24 % for 10a and 12a 
respectively). Combined with the data against A549 cells, this suggests a deleterious effect of 
that particular substituent combination on the antiproliferative properties of these compounds.  
Page 13 of 31 Dalton Transactions
D
al
to
n
Tr
an
sa
ct
io
ns
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
23
 O
ct
ob
er
 2
01
7.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f E
as
t A
ng
lia
 L
ib
ra
ry
 o
n 
31
/1
0/
20
17
 1
0:
20
:4
2.
 
View Article Online
DOI: 10.1039/C7DT03189K
14 
 
By contrast, the mixed-carbene complex [(AdCAAC)Au(ACC)]+ 14a fully inhibited 
both A549 and MCF-7 cells growth at both high and low concentrations, making it the most 
promising complex of the ACC series. For that reason it is the only one that was used for the 
determination of IC50 against our human cancer cell lines panel (Table 2). Like all 
[(CAAC)2M]
+ complexes, 14a demonstrated IC50 values in the low to sub-micromolar range 
against the panel of tested cell lines (IC50 = 0.10 ± 0.01; 2.3 ± 0.9 and 6.1 ± 0.3 µM against 
HL60, MCF-7 and A549 cells respectively). This demonstrates the potential of using a mixed 
[(CAAC)Au(ACC)]+ scaffold for the introduction of functionalities, for example as vectors to 
improve cell uptake selectivity or as imaging probes.  
Mechanistic investigations: inhibition of TrxR Thioredoxin reductase (TrxR) is a 
homodimeric enzyme whose role consists of reducing thioredoxin in an NADPH-dependent 
manner. Thioredoxin (Trx) in turn reduces different proteins including peroxiredoxin 
(involved in the regulation of cellular level of hydrogen peroxide).30 TrxR has been reported 
as a potential intracellular target for complexes of various metals, including Ru, Fe and 
Au.31-33 Among those, Au(I)-NHC complexes were found to be particularly potent TrxR 
inhibitors.3,4,34 Based on those finding we have tested our most toxic complexes 1-8 as 
potential TrxR inhibitors (see Experimental for details). We first performed a screening of all 
complexes at 10 µM against mammalian TrxR. The results are reported in Table 3.  
 
Table 3. Effects of compounds 1 – 8 and 14a and of the pro-ligand salts AdLH, EtLH and 
Me
LH on mammalian TrxR activity. 
Complex Inhibition at 10 µM  (% control)
a 
IC50 ± SD (µM)
b 
1 17.6 n.d. 
2 52.3 n.d. 
3 43.0 n.d. 
4 69.0 4.6 ± 0.3 
5 91.6 2.6 ± 0.8 
6 27.1 n.d. 
7 56.8 6.8 ± 0.1 
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8 52.8 9.4 ± 1.3 
Ad
LH 0.0 n.d. 
Me
LH 0.0 n.d. 
Et
LH 0.0 n.d. 
a
 Results of only one experiment. b Data represent the average ± standard error of three 
experiments. 
 
Although none of the copper containing compounds (1 - 3 and 6) showed any strong 
inhibitory effects on TrxR up to a concentration of 10 µM (less than 50% inhibition), we 
could notice a trend between the bulkiness of the CAAC ligand and the inhibitory activity of 
the corresponding Cu-Cl complexes. Indeed, the adamantyl complex 1 was much less potent 
than the ethyl and methyl complexes 2 and 3. Moreover, for the same substituent (methyl) the 
coordinatively saturated bis-CAAC complex 6 was a much weaker TrxR inhibitor than its 
mono-CAAC analogue 3. Those data are in good agreement with the reported mechanism of 
action of Au(I) complexes which involves the direct coordination of the metal centre to the 
selenocysteine residue of the active site of TrxR.34 The silver and gold complexes, both in the 
mono- and bis-CAAC series, inhibited TrxR at the concentration of 10 µM. Those 
compounds where thus selected for the determination of their IC50 against mammalian TrxR. 
The IC50 values follow the trend (CAAC)MCl < [(CAAC)2M]
+, as already noticed in the 
copper series. The best inhibitor was the mono-CAAC gold complex 5. However the TrxR 
inhibition activity of 5 (IC50 = 2.6 ± 0.8 µM) is almost 10 times lower than that of reported 
NHC-Au-Cl complexes,35 while 8 showed an inhibiting effect similar to the previously 
reported [(NHC)2Au]
+ complexes.36 In particular regarding gold complexes, the higher 
activity of monocarbene complexes versus biscarbene analogues has been observed in several 
recent studies.36a,b,37 The decreased inhibitory activity of 5 compared to other monocarbene 
gold NHC complexes might be explained by the steric protection of the gold centre, which is 
expected to inhibit the ability of the gold centre to bind to the selenocyteine residue of the 
active site of TrxR.  
Altogether, the data show that although inhibition of TrxR might account partially for the 
observed antiproliferative properties of some the CAAC compounds investigated here 
(complexes 4, 5, 7 and 8), the IC50 values are an order of magnitude higher than the IC50 
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values derived from cell growth inhibition. This leads to the conclusion that TrxR inhibition 
is most probably not the main mode of action of the CAAC class of compounds.    
Mechanistic investigations: enhancement of ROS formation. Reactive oxygen species 
(ROS) are naturally produced by mitochondria and are involved in different intracellular 
processes. However, their production, location and quantity is tightly controlled. ROS 
overproduction can induce cellular stress leading to cell death.38 We measured the 
intracellular ROS amount of A549 cells after incubation with the most toxic complexes 1 - 8 
and 14a for 24 hours (Figure 6).  
 
Figure 6: ROS measurement in A549 cells after 24 h incubation with complexes 1 - 8 and 
14a. Data represent the average ± standard error of three experiments.  
 
In the CuCl series there is a clear correlation between the substituent on the CAAC 
ligand and the ability of the compounds to induce ROS production, with the least bulky 
Me2CAAC complex 3 inducing about the same amount of ROS production as the positive 
control H2O2, whereas the most bulky adamantly-substituted complex 1 presented the same 
amount of ROS as the negative control samples. The AdCAAC complexes 1, 4 and 5 did not 
trigger the formation of ROS. None of the cationic bis-CAAC complexes 6 - 8 led to ROS 
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formation either, despite the fact that they contain the sterically least demanding Me2CAAC 
ligand, and despite the differences in their oxidation potentials. Of course, these bis-carbene 
complexes lack readily available coordination sites, and overall the results suggest that the 
accessibility of the metal for further complexation is of particular importance for the 
generation of ROS. Moreover, while (NHC)AuCl and [(NHC)2Au]
+ complexes have been 
reported to enhance the formation of intracellular ROS,35,36a we found that neither neutral 
(CAAC)AuCl 5 nor the homo- and heteroleptic bis-carbene cations [(CAAC)2Au]
+ 8 and 
[(CAAC)Au(ACC)] 14a are able to trigger an increase in intracellular ROS. These data, 
taken together with the relatively low inhibitory effect on TrxR, suggest that the mode of 
action of the CAAC-based complexes is different from that of their analogues with more 
labile NHC ligands. Evidently, the primary inhibitory mechanism of the new CAAC 
complexes remains to be established.  
 
Conclusion 
Acyclic carbene complexes of gold(I) are readily accessible from the reaction of the 
corresponding isocyanide complexes with amines, including amino acid esters. This method 
was explored for its potential for attaching bio-relevant substituents to non-labile carbene 
ligands. These ACC complexes, together with eight neutral and cationic CAAC-based 
complexes of Cu, Ag and Au, were screened for their antiproliferative properties on a panel 
of human cancer cells. Compared to the more conventional imidazolylidene-type NHC 
complexes, CAAC compounds offer the advantage that they are not prone to ligand exchange 
and retain their structural integrity in aqueous media and under physiological conditions. 
While none of the chloride or PTA derivatives demonstrated particularly promising cytotoxic 
effects, the CAAC-containing complexes showed interesting IC50 values down to sub-
micromolar levels. In particular, the cationic [(Me2CAAC)2M]
+ complexes (6 – 8, M = Cu, Ag 
and Au) and the mixed-carbene complex [(AdCAAC)Au(ACC)]+ 14a proved to be the most 
potent of the series. The CAAC containing complexes appeared to only poorly inhibit TrxR, 
suggesting the TrxR inhibition by binding to the selenium site is unlikely to be the primary 
intracellular target. While Cu complexes with sterically less-hindered CAAC ligands 
appeared to enhance the formation ROS, none of the other CAAC-containing complexes 
seemed to do so up to a concentration of 100 µM. Overall, our study documents that CAAC-
based complexes show promise for anticancer applications. The use of mixed CAAC/ACC 
combinations is of particular interest since it opens the way to further functionalization of this 
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scaffold. Studies to understand the possible mode of action of those compounds as well as 
their conjugation to bio-vectors are currently ongoing.  
 
 
Experimental 
General Remarks. Unless stated otherwise all reactions were carried out in air. Solvents were 
distilled and dried as required. The carbene ligands Me2CAAC, Et2CAAC, AdCAAC,19 and 
complexes [(Et2CAAC)2Cu]I,
22b and (CAAC)MCl (M = Cu, Ag, Au; X = Cl, Br, I),21-24 were 
obtained according to literature procedures. 1H, 13C{1H} and 19F NMR spectra were recorded 
using a Bruker Avance DPX-300 MHz NMR spectrometer. 1H NMR spectra (300.13 MHz) 
and 13C{1H} (75.47 MHz) were referenced to CD2Cl2 at δ 5.32 (
13C, δ 53.84), C6D6 at δ 7.16 
(13C, δ 128.4), CDCl3 at δ 7.26 (
13C, δ 77.16) or C6D5Br at δ 7.30 for the most downfield 
signal (13C, δ 122.5) ppm. 19F NMR spectra (282.4 MHz) were referenced externally to 
CFCl3 and internally to C6F6 (δF -164.9). IR spectra were recorded using a Perkin-Elmer 
Spectrum One FT-IR spectrometer equipped with a diamond ATR attachment. 
Electrochemical experiments were performed using an Autolab PGSTAT 302N computer-
controlled potentiostat. Cyclic voltammetry (CV) was performed using a three-electrode 
configuration consisting of either a glassy carbon macrodisk working electrode (GCE) 
(diameter of 3 mm; BASi, Indiana, USA) combined with a Pt wire counter electrode (99.99 
%; GoodFellow, Cambridge, UK) and an Ag wire pseudoreference electrode (99.99 %; 
GoodFellow, Cambridge, UK). The GCE was polished between experiments using alumina 
slurry (0.3 µm), rinsed in distilled water and subjected to brief sonication to remove any 
adhering alumina microparticles. The metal electrodes were then dried in an oven at 100 °C 
to remove residual traces of water, the GCE was left to air dry and residual traces of water 
were removed under vacuum. The Ag wire pseudoreference electrodes were calibrated to the 
ferrocene/ferrocenium couple in MeCN at the end of each run to allow for any drift in 
potential, following IUPAC recommendations.39 All electrochemical measurements were 
performed at ambient temperatures under an inert Ar atmosphere in MeCN containing 
complex under study (0.14 mM) and supporting electrolyte [nBu4N][PF6] (0.13 mM). Data 
were recorded with Autolab NOVA software (v. 1.11). Elemental analyses were performed 
by London Metropolitan University. Compound 9b has been synthesized according to 
reported procedure.28 
 
Synthesis of ClAu{C(NHxylyl)(pyrrolidine)} (9a) 
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Xylylisocyanide gold chloride (50 mg, 0.18 mmol, 1 eq.) was dissolved in dichloromethane. 
Pyrrolidine (49 mg, 0.90 mmol, 5 eq.) was added to this solution. The mixture was left 
overnight at room temperature in the dark, filtered through celite and then washed with 
saturated aqueous ammonium chloride solution. The clear solution was dried with sodium 
sulphate for 1h, filtered and the volatiles were removed under vacuum. The product was 
precipitated with a dichloromethane/hexane mixture to form a white powder which was dried 
under vacuum (47 mg, 0.14 mmol, 79%). Anal. Calcd for C13H18N2AuCl (434.7): C, 35.92; 
H, 4.17; N, 6.44. Found: C, 36.08; H, 4.25; N, 6.47. 1H NMR (CDCl3, 300 MHz): δ 7.13 (m, 
3H, Harom. xylyl), 6.61 (s, 1H, NH), 4.05 (t, 
3
JH-H = 9 Hz, 2H, H
1 or H4), 3.40 (t, 3JH-H = 6 Hz, 
2H, H1 or H4), 2.23 (m, 8H, Mexylyl + H
2 or H3), 2.00 (p, 3JH-H = 6 Hz, 2H, H
2 or H3). 13C{1H} 
NMR (CDCl3, 75 MHz): 190.9 (s, Ccarbene), 137.5 (s, Carom. ipso), 136.3 (s, Carom. ortho), 128.8 (s, 
CHarom.), 128.6 (s, CHarom.),  56.1 (s, CH2
1/4), 45.5 (s, CH2
1/4), 25.6 (s, CH2
2/3), 24.4 (s, 
CH2
2/3), 19.2 (s, CH3). IR νmax (neat)/cm
-1: 3725 (NH), 1551 (carbene). 
 
Synthesis of ClAuC(NHxylyl)(sarcosine) (10a) 
Sarcosine hydrochloride (210 mg, 1.50 mmol) was dissolved in acetonitrile and stirred with 
potassium carbonate (207 mg, 1.5 mmol) for 1h. The resulting mixture was paper-filtered and 
(xylylNC)AuCl (110 mg, 0.30 mmol) was added and left to mix for an hour. The solution 
was purified by filtration through Celite, washing with ammonium chloride and drying over 
anhydrous Na2SO4 for 1h. This mixture was then paper-filtered and the volatiles were 
removed under vacuum. The product was precipitated with hexane and diethyl ether to give 
an orange powder (95 mg, 0.09 mmol, 66%). Anal. Calcd for C14H20N2O2AuCl (480.74): C, 
34.98; H, 4.19; N, 5.83. Found C, 35.02; H, 4.28; N, 5.91. 1H NMR (CDCl3, 300 MHz): δ 
7.15 (m, 4H, Harom. xylyl + NH), 4.81 (s, 2H, NCH2), 4.24 (q, 
3
JH-H = 7.0 Hz, 2H, OCH3), 3.16 
(s, 3H, NCH4), 2.24 (s, 6H, CH3 xylyl), 1.31 (t, 
3
JH-H = 7 Hz, 3H, CH2CH3). 
13C{1H} NMR 
(CDCl3, 75 MHz): 196.4 (s, Ccarbene), 168.6 (s, C=O), 136.9 (s, Carom. ipso), 136.3 (s, Carom. ortho), 
128.9 (s, CHarom.), 128.8 (s, CHarom.), 62.1 (s, OCH2), 61.2 (s, NCH2), 35.9 (s, NCH3), 18.9 (s, 
CH3 xylyl), 14.3 (s, CH2CH3). IR νmax (neat)/cm
-1: 3219 (NH), 1745 (C=O), 1547 (carbene). 
 
Synthesis of ClAuC(NH
t
Bu)(Sarcosine)  (10b) 
The compound was prepared as described for 10a, from sarcosine hydrochloride (44 mg, 0.32 
mmol) and t-butyl isocyanide gold chloride (50 mg, 16 mmol) in acetonitrile. Drying under 
vacuum resulting in a purple powder (58 mg, 0.27 mmol, 84%,). Anal. Calcd for 
C10H20N2O2AuCl (432.7): C, 27.76; H, 4.66; N, 6.47. Found: C, 27.71; H, 4.70; N, 6.35. 
1H 
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NMR (CDCl3, 300 MHz): δ 5.95 (s, 1H, NH), 4.85 (s, 2H, NCH2), 4.22 (q, 
3
JH-H = 7 Hz, 2H, 
OCH2), 2.96 (s, 3H, NCH3), 1.65 (s, 9H, 
tBu), 1.30 (t, 3JH-H = 7 Hz, 3H, CH2CH3). 
13C{1H} 
NMR (CDCl3, 75 MHz): 193.6 (s, Ccarbene), 168.9 (s, C=O), 62.7 (s, OCH2), 62.0 (s, NCH2), 
55.1 (s, C(CH3)3), 34.6 (s, NCH3), 31.8 (s, C(CH3)3), 14.27 (s, CH2CH3). IR νmax (neat)/cm
-1: 
3364 (NH), 1734 (C=O), 1548 (carbene). 
 
Synthesis of [(1,3,5-triaza-7-phosphaadamantane)Au{C(NHxylyl)(pyrrolidine)}]PF6 
(11a) 
ClAu{C(NHxylyl)(pyrrolidine)} (42 mg, 0.10 mmol) was dissolved in acetone and 1,3,5-
triaza-7-phosphaadamantane (PTA, 16 mg, 0.10 mmol) and potassium hexafluorophosphate 
(92 mg, 0.50 mmol) were added. The mixture was stirred overnight at room temperature, 
filtered and the acetone removed under vacuum. The product was taken up in 
dichloromethane and precipitated with hexane to give a white powder (60 mg, 0.07 mmol, 
70%). 1H NMR (DMSO, 300 MHz): δ 9.41 (s, 1H, NH), 7.21 (m, 3H, Harom.), 4.45 (d, 
3
JH-H = 
15 Hz, 3H, NCH2N), 4.28 (d, 
3
JH-H = 15 Hz, 3H, NCH2N), 4.02 (s, 6H, PCH2N), 3.78 (t, 
3
JH-H 
= 6 Hz, 2H, H1 or H4), 3.40 (t, 3JH-H = 6 Hz, 2H, H
1 or H4), 2.19 (s, 6H, CH3 xylyl), 2.05 (m, 
2H, H2 or H3), 1.89 (m, 2H, H2 or H3). 13C{1H} NMR (DMSO, 75 MHz): (Ccarbene not 
visible), 138.2 (s, Carom. ipso), 136.2 (s, Carom. ortho), 128.2 (s, CHarom.), 127.9 (s, CHarom.), 71.7 
(s, NCH2N), 54.8 (s, CH2
1/4), 47.0 (s, CH2
1/4), 51.1 (broad s, PCH2N), 30.8 (s, CH2
2/3), 24.6 
(s, CH2
2/3), 18.6 (s, CH3 xylyl). 
31P{1H} NMR (DMSO, 121 MHz): -51.2 (broad s, 1P, PTA), -
144.2 (h, 1JP-F = 708 Hz, 1P, PF6). IR νmax (neat)/cm
-1: 3160 (NH), 1557 (carbene). 
 
Synthesis of [(1,3,5-triaza-7-phosphaadamantane)Au{C(NH
t
Bu)(pyrrolidine)}]PF6 (11b) 
The complex was prepared as described for 11a, from ClAuC(NHtBu)(pyrrolidine) (27 mg, 
0.07 mmol), 1,3,5-triaza-7-phosphaadamantane (11 mg, 0.07 mmol) and potassium 
hexafluorophosphate (64 mg, 0.35 mmol) as a white powder (35 mg, 0.05 mmol, 77%). Anal. 
Calcd for C15H30N5PAuPF6 (671.9): C, 28.60; H, 4.88; N, 10.42. Found: C, 28.62; H, 5.21; 
N, 10.20. 1H NMR (DMSO, 300 MHz): δ 7.19 (s, 1H, NH), 4.57 (d, 3JH-H = 12 Hz, 3H, 
NCH2N), 4.36 (d + s, 
3
JH-H = 12 Hz, 3H + 6H, NCH2N + PCH2N), 3.82 (broad s, 2H, CH2
1/4), 
3.28 (broad s, 2H, CH2
1/4), 1.93 (broad s, 2H, CH2
2/3), 1.81 (broad s, 2H, CH2
2/3), 1.49 (s, 9H, 
tBu). 13C{1H} NMR (DMSO, 75 MHz): 202.3 (s, Ccarbene), 71.8 (d, 
3
JP-C = 8 Hz,
 NCH2N),  
55.9 (s, CH2
1/4), 53.5 (s, C(CH3)3), 50.9 (broad s, PCH2N), 46.1 (s, CH2
1/4), 31.8 (s, C(CH3)3), 
24.4 (s, CH2
2/3), 24.3 (s, CH2
2/3). 31P{1H} NMR (DMSO, 121 MHz): -52.0 (broad s, 1P, 
PTA), -144.21 (h, 1JP-F = 708 Hz, 1P, PF6). IR νmax (neat)/cm
-1: 3360 (NH), 1545 (carbene). 
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Synthesis of [(1,3,5-triaza-7-phosphaadamantane)Au{C(NHXylyl)(sarcosine)}]PF6 (12a) 
The complex was prepared as described for 11a, from ClAu{C(NHxylyl)(sarcosine)} (50 mg, 
0.104 mmol), 1,3,5-triaza-7-phosphaadamantane (16 mg, 0.104 mmol) and potassium 
hexafluorophosphate (96 mg, 0.52 mmol). The product was isolated as a pink powder as a 
mixture of two stereoisomers in a ratio 3/1 (66 mg, 0.09 mmol, 85%). Anal. Calcd for 
C20H32N5O2PAuPF6 (747.41): C, 32.14; H, 4.32; N, 9.37. Found: C, 32.05; H, 4.36; N, 9.42. 
1H NMR (CD3CN, 300 MHz): δ 8.31 (broad s, 0.75H, NH isomer 1), 8.20 (broad s, 0.25H, 
NH isomer 2), 7.23 (m, 3H, CHarom.), 4.55 (s, 1.5H, NCH2 isomer 1), 4.45 (d, 
3
JH-H = 13 Hz, 
3H, NCH2N), 4.34 (d, 
3
JH-H = 13 Hz, 3H, NCH2N), 4.26 (s, 0.5H, NCH2 isomer 2), 4.23 (q, 
3
JH-H = 7 Hz, 2H, OCH2), 3.96 (s, 6H, PCH2N), 3.45 (s, 0.7H, NCH3 isomer 2), 3.13 (s, 2.3H, 
NCH3 isomer 1), 2.24 (s, 6H, CH3 xylyl), 1.27 (q, 
3
JH-H = 7 Hz, 3H, CH2CH3). 
13C{1H} NMR 
(CD3CN, 75 MHz): only major isomer observed, (Ccarbene not visible), 169.8 (s, C=O), 137.8 
(s, Carom. ipso), 129.6 (s, Carom. ortho), 129.3 (s, CHarom.), 73.1 (d, 
3
JP-C = 8 Hz,
 NCH2N), 62.6 (s, 
OCH2), 60.5 (s, NCH2 observed by 
1H-13C{1H} correlation), 51.4 (d, 1JP-C = 19 Hz,
 PCH2N), 
37.4 (s, NCH3), 18.7 (s, CH3 xylyl). 14.6 (s, CH2CH3). 
31P{1H} NMR (CD3CN, 121 MHz): -
52.4 (broad s, 1P, PTA), -144.6 (h, 1JP-F = 708 Hz, 1P, PF6). IR νmax (neat)/cm
-1: 3340 (NH), 
1740 (C=O), 1554 (carbene).  
 
Synthesis of [(1,3,5-triaza-7-phosphaadamantane)Au{C(NH
t
Bu)(sarcosine)}]PF6 (12b) 
The complex was prepared as described for 11a, from ClAu{C(NHtBu)(sarcosine)} (50 mg, 
0.12 mmol), 1,3,5-triaza-7-phosphaadamantane (19 mg, 0.12 mmol) and potassium 
hexafluorophosphate (110 mg, 0.60 mmol) as a red powder which was a mixture of four 
stereoisomers in a ratio 46/24/21/9. (38 mg, 0.05 mmol, 45%,). Anal. Calcd for 
C16H32N5O2PAuPF6 (699.37): C, 27.48; H, 4.61; N, 10.01. Found: C, 27.53; H, 4.58; N, 9.90. 
1H NMR (DMSO, 300 MHz): δ 9.16 (s, 0.21H, NH isomer 3),  8.12 (s, 0.24H, NH isomer 3),  
7.66 (s, 0.09H, NH isomer 4), 7.52 (s, 0.46H, NH isomer 1), 4.72 (s, 1H, NCH2 isomer 1), 
4.54 (d, 3JH-H = 13 Hz, 3H, NCH2N), 4.45 (s, 0.5H, NCH2 isomer 2), 3.45 (m, 9.4H, NCH2N 
+ PCH2N + NCH2 isomer 3 and 4), 4.17 (q, 
3
JH-H = 7 Hz, 2H, OCH2), 3.45 (s, 0.6H, NCH3 
isomer 3 and 4), 3.04 (s, 0.7H, NCH3 isomer 2), 2.97 (s, 1.5H, NCH3 isomer 1), 1.52 (s, 4.3H, 
tBu isomer 1), 1.49 (s, 2.4H, tBu isomer 2), 1.32 (s, 2.9H, tBu isomer 3 and 4), 1.24 (t, 3JH-H = 
7 Hz, 3H, CH2CH3). 
13C{1H} NMR (DMSO, 75 MHz): only major isomer observed, (Ccarbene 
not visible), 169. (s, C=O), 71.8 (d, 3JP-C = 8 Hz,
 NCH2N), 61.2 (s, OCH2), 61.1 (s, NCH2), 
54.3 (s, C(CH3)3), 50.4 (d, 
1
JP-C = 19 Hz,
 PCH2N), 36.4 (s, NCH3), 31.7 (s, C(CH3)3), 14.2 (s, 
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CH2CH3). 
31P{1H} NMR (DMSO, 121 MHz): -50.4 (broad s, 1P, PTA), -144.22 (h, 1JP-F = 
708 Hz, 1P, PF6). IR νmax (neat)/cm
-1: 3354 (NH), 1740 (C=O), 1549 (carbene). 
 
Synthesis of [(
Ad
CAAC)Au(CNxylyl)]SbF6 (13a)  
A Schlenk flask was charged with (AdCAAC)AuCl (121 mg, 0.2 mmol), AgSbF6 (70 mg, 0.2 
mmol) and CH2Cl2 (2 mL). The resulting suspension was stirred for 1 h in the dark. The 
mixture was filtered through a Celite pad (2 cm), which was washed with another 8 mL of 
CH2Cl2. The colourless solution was concentrated to ca. 2 mL and an excess of xylyl 
isocyanide (52 mg, 0.4 mmol) was added, followed by stirring at room temperature for 4 h. 
The solution was concentrated and the product precipitated with hexanes (15 mL), 
centrifuged and washed with hexanes (5 mL). The volatiles were removed under vacuum to 
give the complex as a white solid (169 mg, 0.18 mmol, 90 %). Anal. Calcd. for 
C36H48AuF6N2Sb (940.24): C, 45.93; H, 5.14; N, 2.98. Found: C, 45.82; H, 5.04; N, 3.03. 
1H 
NMR (300 MHz, CD2Cl2): δ 7.53 (t, J = 8.0 Hz, 1H, CH-aromatic), 7.39–7.34 (m, 2H CH-
meta aniline and 1H CH-para CNxylyl), 7.18 (d, J = 7.6 Hz, CH-aromatic CNxylyl), 3.48 (br 
d, J = 12.2 Hz, 2H, CH2), 2.77 (sept, J = 6.7 Hz, 2H, CH(CH3)2), 2.45–1.86 (m, 14H, 
adamantyl CH and CH2), 2.27 (s, 6H, 2CH3, CNxylyl), 1.44 (s, 6H, 2CH3), 1.38 (d, J = 6.7 
Hz, 6H, CH(CH3)2) overlapping with 1.36 (d, J = 6.7 Hz, 6H, CH(CH3)2) ppm. 
13C{1H} 
NMR (75 MHz, CD2Cl2): δ 246.5 (C carbene), 145.3 (o-C aniline), 136.9 (o-C, CNxylyl) 
135.2 (Cipso aniline), 132.2 (p-CH, CNxylyl), 131.0 (p-CH, aniline), 128.9 (m-CH, CNxylyl), 
125.8 (m-CH aniline), 123.5 (NCipso CNxylyl), 80.1 (Cq), 65.4 (Cq), 48.5 (CH2), 38.9 (CH2), 
37.4, 36.7, 34.4 (CH2), 29.5, 29.4, 28.3, 27.2, 27.1, 23.2, 18.6 (CH3 CNxylyl) ppm. IR νmax 
(neat)/cm-1: 2215 (CNxylyl).  
 
Synthesis of [(
Ad
CAAC)Au{C(NHxylyl)(pyrrolidine)}]SbF6 (14a)  
The solution of 13a (50 mg, 0.053 mmol) and pyrrolidine (9 µL, 0.106 mmol) in 6 mL of 
MeCN was stirred overnight in the dark, filtered through a thin layer of Celite, washed with a 
saturated ammonium chloride solution, and dried with sodium sulphate. The solution was 
filtered and volatiles were removed under vacuum. The residue was taken up in 
dichloromethane and the product was precipitated with hexane as a white powder (41 mg, 
0.040 mmol, 75%). Anal. Calcd. for C40H57AuF6N3Sb (1011.32): C, 47.44; H, 5.67; N, 4.15. 
Found: C, 47.55; H, 5.78; N, 4.36. 1H NMR (300 MHz, CD2Cl2): δ 7.46 (t, J = 8.2 Hz, 1H, p-
CH aniline), 7.32 (t, 2H m-CH aniline), 7.18 (t, J = 6.1 Hz, 1H, p-CH xylyl), 7.10 (d, J = 6.1 
Hz, m-CH xylyl), 6.85 (br s, 1H, NH), 3.28 (t, J = 7.1 Hz, 2H, NCH2 (C4) pyrrolidine), 2.71 
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(sept, J = 6.7 Hz, 2H, CH(CH3)2), 2.59 (br d, J = 10.2 Hz, 2H, CH2), 2.48 (t, J = 6.7 Hz, 2H, 
NCH2 (C1) pyrrolidine), 2.25–1.53 (m, 14H, adamantyl CH and CH2) overlapping with 2.12 
(s, 6H, 2CH3, CNxylyl) and 2.00 (m, J = 7.1 Hz, 2H, CH2 (C3) pyrrolidine) and 1.58 (m, 2H, 
CH2 (C2) pyrrolidine), 1.32 (s, 6H, 2CH3) overlapping with 1.33 (d, J = 6.7 Hz, 6H, 
CH(CH3)2) and 1.31 (d, J = 6.7 Hz, 6H, CH(CH3)2) ppm. 
13C{1H} NMR (75 MHz, CD2Cl2): 
δ 255.6 (C carbene CAAC), 201.6 (C open chain carbene), 145.6 (o-C aniline), 137.5 (NCipso 
CNxylyl), 136.9 (o-C, CNxylyl), 136.4 (Cipso aniline), 130.3 (p-CH, aniline), 129.1 (p-CH 
overlapping with m-CH, CNxylyl), 125.7 (m-CH aniline), 79.0 (Cq), 65.5 (Cq), 53.86 (NCH2, 
C1 pyrrolidine overlaps with residual CHDCl2), 48.7 (CH2), 46.0 (NCH2 C4 pyrrolidine), 
38.8 (CH2), 37.3, 35.2, 34.3 (CH2), 29.5, 29.4, 28.0, 27.2, 26.5, 25.1 (CH2, C3 pyrrolidine), 
24.7 (CH2, C2 pyrrolidine), 23.2 (CH3), 18.7 (CH3 CNxylyl) ppm. IR νmax (neat)/cm
-1: 3331 
(NH), 1546 (carbene).  
 
Biological testing 
Antiproliferation assay. Human HL 60 and A549 cancer cell lines (from ECACC) were 
cultured in RPMI 1640 medium with 10% fetal calf serum, 2mM L-glutamine, 100U/mL 
penicillin and 100 µg/mL streptomycin (Invitrogen). Cells were maintained in a humidified 
atmosphere at 37 °C and 5% CO2. The human MCF-7 cancer cell line (from ECACC) were 
cultured in DMEM medium with 10% fetal calf serum, 2mM L-glutamine, 100U/mL 
penicillin and 100 µg/mL streptomycin (Invitrogen). Cells were maintained in a humidified 
atmosphere at 37 °C and 5% CO2. Inhibition of cancer cell proliferation was measured by the 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium 
(MTS) assay using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay 
(Promega) and following the manufacturer’s instructions. Briefly, cells (3 × 104/100 µL for 
HL 60 and 8 × 103/100 µL for both A549 and MCF-7) were seeded in 96-well plates and left 
untreated or treated with 1 µL of DMSO (vehicle control) or 1 µL of complexes diluted in 
DMSO at different concentrations in triplicate for 72 h at 37 °C with 5% CO2. Following this, 
MTS assay reagent was added for 4 h and absorbance measured at 490 nm using a Polarstar 
Optima microplate reader (BMG Labtech). IC50 values were calculated using GraphPad 
Prism Version 5.0 software. 
 
Inhibition of mammalian Thioredoxin Reductase 
To determine the inhibition of mammalian TrxR, an established microplate-reader-based 
assay was performed. (Ref: Chem. Eur. J. 2017, 23, 1869 – 1880) For this purpose, 
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commercially available rat liver TrxR (Sigma Aldrich) was used and diluted with distilled 
water to achieve a concentration of 3.58 U/mL. The compounds were freshly dissolved as 
stock solutions in DMSO. Aliquots (25 mL) of the enzyme solution and either potassium 
phosphate buffer (25 µL; pH 7.0) containing the compounds in graded concentrations or 
buffer (25 µL) without the compounds, but DMSO (positive control) were added. A blank 
solution (DMSO in buffer; 50µL) was also prepared (final concentrations of DMSO: 0.5% 
v/v). The resulting solutions were incubated with moderate shaking for 75 min at 37°C in a 
96-well plate. A portion (225 µL) of reaction mixture (1 mL of reaction mixture consists of: 
500 µL potassium phosphate buffer pH 7.0, 80 µL EDTA solution (100 mM, pH 7.5), 20 µL 
BSA solution (0.2 %), 100 µL of NADPH solution (20 mM), and 300 µL distilled water) was 
added to each well and the reaction was immediately initiated by the addition of 20 mM 
ethanolic DTNB solution (25 µL). After thorough mixing, the formation of 5-TNB was 
monitored with a microplate reader at 405 nm ten times in 35 second intervals for about 6 
min. The increase in 5-TNB concentration over time followed a linear trend (r2 = 0.990), and 
the enzymatic activities were calculated as the slopes (increase in absorbance per second) 
thereof. For each tested compound, the non-interference with the assay components was 
confirmed by a negative control experiment using an enzyme-free test solution. IC50 values 
were calculated as the concentration of the compound decreasing the enzymatic activity of 
the untreated control by 50%, and are given as the means and error of three repeated 
experiments. 
 
ROS assay. 100 µL of A549 cells were seeded at a density of 1 x 105 cells/mL in a 96-well 
black plate with a transparent bottom. The cells were incubated at 37 °C for 24h. The 
medium was removed, and replaced with 50 µM H2DCFDA in phosphate buffer solution for 
40 min. H2DCFDA was removed and replaced with fresh medium and the cells were left for 
recovery for 20 min at 37 °C. Basal fluorescence was measured at 485/520 nm on a 
POLARstar Optima. Cells were incubated with 10 µM, 50µM, or 100 µM of compounds, 1% 
DMSO (negative control) and 100 µM of H2O2 (positive control) for 24h. Fluorescence was 
read at 485/520 nm. Basal fluorescence was subtracted from the fluorescence in treated cells 
to calculate the amount of fluorescence caused by the compounds.  
 
X-Ray Crystallography.  
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Crystals suitable for X-ray diffraction were obtained by the slow evaporation of 
dichloromethane/hexane solutions for 9a, 10a, 10b and 14a, acetone/toluene solutions for 
11a and 11b, or by layering a CH2Cl2 solution with hexanes for 13a. Complex 11a 
crystallizes as a solvate with one disordered molecule of CH2Cl2. Two positions for CH2Cl2 
molecule were successfully resolved upon cooling the crystal of 11a to 140 K leading to 
occupancies 0.6 and 0.4. The disordered CH2Cl2 molecule was refined in the geometry of 
isosceles triangle and DFIX restraints on C1S–Cl1 bond length (1.72(1) Å) and Cl1···Cl2 
distance (2.90(1) Å). The atom C3 was disordered over two half-populated positions for 
complex 14a. Crystals were mounted in oil on glass fibres and fixed in the cold nitrogen 
stream on a diffractometer. Data were collected using an Oxford Diffraction Xcalibur-
3/Sapphire3-CCD diffractometer, using graphite monochromated Mo Kα radiation (λ = 
0.71073 Å) at 140 K. Data were processed using CrystAlisPro-CCD and –RED software.40 
The principal crystallographic data and refinement parameters are listed in Table 4. The 
structures were solved by direct methods and refined by the full-matrix least-squares against 
F2 in an anisotropic (for non-hydrogen atoms) approximation. All hydrogen atom positions 
were refined in isotropic approximation in “riding” model with the Uiso(H) parameters equal 
to 1.2 Ueq(Ci), for methyl groups equal to 1.5 Ueq(Cii), where U(Ci) and U(Cii) are 
respectively the equivalent thermal parameters of the carbon atoms to which the 
corresponding H atoms are bonded. All calculations were performed using the SHELXTL 
software.41   
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Table 4. Summary of crystallographic data and structure refinement  
 9a 10a 10b 11a 13a 14a 
CCDC number 1568251 1568247 1568252 1568248 1568249 1568250 
Temperature (K) 140 100 100 140.0 140 100 
Empirical formula C13H18AuClN2 C14H20AuClN2O2 C10H20AuClN2O2 C20H32AuCl2F6N5P2 C36H48AuF6N2Sb C40H57AuF6N3Sb 
Molecular weight 434.71 480.74 432.70 786.31 941.48 1012.60 
Crystal system Monoclinic Orthorhombic Monoclinic Monoclinic Monoclinic Monoclinic 
Space group P21/c P212121 P21/c P21/n P21/c P21/n 
Crystal colour, habit Colourless/block Colourless/needle Colourless/block Colourless/block Colourless/plate Colourless/block 
Crystal size (mm) 0.23×0.15×0.08 0.20×0.05×0.05 0.08×0.04×0.04 0.18×0.07×0.06 0.27×0.16×0.09 0.08×0.07×0.05 
a (Å) 7.3404(2) 10.5095(2) 12.0876(2) 13.6153(2) 9.9471(3) 9.7273(3) 
b (Å) 13.3484(3) 12.0198(3) 9.43950(10) 12.5760(2) 26.0651(8) 13.1815(3) 
c (Å) 14.7732(4) 13.0933(2) 13.5065(2) 16.6816(3) 13.5998(5) 30.9171(11) 
α (°) 90 90 90 90 90 90 
β (°) 102.267(2) 90 114.107(2) 106.059(2) 95.681(3) 91.749(4) 
γ (°) 90 90 90 90 90 90 
V (Å3) 1414.47(6) 1653.97(6) 1406.69(3) 2744.86(8) 3508.7(2) 3962.4(2) 
Z 4 4 4 4 4 4 
Dcalc (g cm
–3) 2.041 1.931 2.043 1.903 1.782 1.697 
2θmax (°) 28.00 27.48 27.48 28.00 26.37 27.49 
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Abs. coeff., µ(Mo-Kα) (cm
–1) 10.570 9.058 10.638 5.732 5.006 4.440 
Tmax/Tmin 0.4852/0.1948 0.6601/0.2645 0.6756/0.4832 0.7249/0.4252 0.6615/0.3451 0.8085/0.7177 
collected reflections 13835 27496 16303 28505 24982 27773 
independent reflections 3419 3780 3218 6603 7155 9081 
observed reflections (I > 2σ(I)) 3273 3659 3132 6075 6372 8662 
Rint 0.0270 0.0654 0.0254 0.0270 0.0364 0.0282 
Number of parameters 170 185 150 355 423 471 
R1 (on F for observed 
reflexions) 
0.0205 0.0256 0.0125 0.0234 0.0211 0.0269 
wR2 (on F
2 for all reflexions) 0.0544 0.0557 0.0278 0.0596 0.0441 0.0638 
Weighting scheme w–1=σ2(Fo
2) + (aP)2 + bP, where P = 1/3(Fo
2 + 2Fc
2) 
A 0.03 0.03 0.01 0.03 0.008 0.03 
B 1.8 0.1 2.1 2.5 2.3 5.7 
F(000) 824 920 824 1536 1848 2008 
Goodness-of-fit 1.051 1.027 0.892 1.041 1.047 1.041 
∆ρmax/∆ρmax (e Å
–3) 0.903/–1.138 1.484/–1.226 0.424/–0.345 0.927/–0.829 0.420/–0.556 1.198/–1.195 
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